SCHEMBL9150195

SCHEMBL9150195

CC(C(O)C(=O)O)C(O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.60
TP53 P04637 1/20 0.56
SLC7A5 Q01650 1/20 0.38
CYP2C9 P11712 1/20 0.38
PDE4A P27815 1/20 0.38
CYP2C19 P33261 2/20 0.36
NFKB1 P19838 1/20 0.36
CYP2D6 P10635 1/20 0.35
RNPEP Q9H4A4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14661514 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL8768820 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL14661314 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL7440928 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL14661315 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL14661752 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL14661513 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL14661422 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL16885208 0.87 TSHR (0.53) TSHRTP53SLC7A5CYP2C9PDE4A
SCHEMBL22988565 0.84 TSHR (0.50) TSHRTP53SLC7A5CYP2C9PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0249222-B1 RADIATION CURABLE RESIN Toyo Boseki Kabushiki Kaisha (JP) 1993-01-20 EP claimed
US-20230295195-A1 ANTIMICROBIAL ORGANOSILANES Tipikos Pharmaceuticals, Inc. (US) 2023-09-21 US disclosed
CN-104130629-B Conductive ink and preparation method thereof SHENZHEN SUCCESS ELECTRONICS LTD. (CN) 2016-01-20 CN disclosed
US-8912304-B2 Polyol-based polymers MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-12-16 US disclosed
CN-104130629-A Electric-conduction ink and preparation method thereof SHENZHEN SUCCESS ELECTRONICS CO LTD 2014-11-05 CN disclosed
US-20110008277-A1 POLYOL-BASED POLYMERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-01-13 US disclosed
US-5451642-A Molding materials SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-09-19 US disclosed
US-5428091-A Curable blends for molding, shaping; chemical resistance, mechanical properties SUMITOMO CHEMICAL CO., LTD. (JP) 1995-06-27 US disclosed
EP-0408255-B1 Thermoplastic resin composition SUMITOMO CHEMICAL CO (JP) 1995-05-17 EP disclosed
EP-0485598-B1 THERMOPLASTIC RESIN COMPOSITION SUMITOMO CHEMICAL CO (JP) 1995-04-12 EP disclosed
US-5070151-A THERMOPLASTIC RESIN BLENDS OF POLYPHENYLENE ETHERS AND POLYLAC TAMS SUMITOMO CHEMICAL CO., LTD. (JP) 1991-12-03 US disclosed
EP-0456259-A1 Thermoplastic resin composition and article comprising the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-11-13 EP disclosed
US-5019615-A Polyphenylene ether/polyester blend with nitrodiamine compound SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1991-05-28 US disclosed
US-5017663-A Polyphenylene ether, polyamide blend SUMITOMO CHEMICAL CO., LTD. (JP) 1991-05-21 US disclosed
EP-0408255-A1 Thermoplastic resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-01-16 EP disclosed
EP-0403056-A2 Thermoplastic resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-12-19 EP disclosed
EP-0394016-A2 Resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-10-24 EP disclosed
EP-0391733-A2 Thermoplastic resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-10-10 EP disclosed
EP-0381391-A2 Resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-08-08 EP disclosed
EP-0368283-A2 Resin composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110008277-A1 POLYOL-BASED POLYMERS SORD, SUCLG2, SUCLG1 TSHR 4876/4885TP53 1360/4885SLC7A5 1629/4885
US-20230295195-A1 ANTIMICROBIAL ORGANOSILANES ARG1, ACMSD, AAAS TSHR 4128/4885TP53 1046/4885SLC7A5 246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.